mAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules. Global Monoclonal Antibodies market continues to gain momentum with the rapid increase in adoption of these products for various indications. At present, there are forty-seven monoclonal antibody products have been approved in the United States or Europe for the treatment of a wide range of diseases, and many of these products have also been approved in the global markets. At the current approval rate of four new products releasing every year, approximately 70 monoclonal antibody products are expected to be present on the market by 2021.
Global Monoclonal Antibodies market is driven by increasing R & D activities in genomics, owing to rapid advancements of our understanding of disease at a molecular level. The development of new molecules is expected to play a prominent role in the future of the market due to the cost effectiveness of this technology. However huge cost and time associated with the identification and development of potential molecules is a major factor hindering the growth of the market.
The Global Market for Monoclonal Antibodies is broadly categorized by Source, Indication, End User, Application, and Region.
1) By source Murine Chimeric Humanized Human
2) By Indication Cancer a) Blood Cancer b) Breast Cancer c) Colorectal Cancer d) Lung Cancer e) Pancreatic Cancer f) Others Autoimmune diseases Infectious diseases Cardiovascular diseases CNS disorders Others
3) By End User Hospitals/Clinics Research Institute Diagnostic Laboratories
4) By application Medical Experimental a) Western Blot b) ELISA c) Radioimmune Assays d) Immunofluorescence e) Others
5) By Geography North America Europe Asia-Pacific Latin America Middle-East & Africa
Some of the major companies dominating the market, by their products include GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China).
About us: Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
